Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE—Reply
1. Pawar A, Gagne JJ, Gopalakrishnan C, et al. Association of type of oral anticoagulant
dispensed with adverse clinical outcomes in patients extending anticoagulation therapy …
dispensed with adverse clinical outcomes in patients extending anticoagulation therapy …
[引用][C] Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply
K Bykov, JJ Gagne - JAMA, 2022 - pubmed.ncbi.nlm.nih.gov
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply Type of Oral …
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply Type of Oral …
[引用][C] Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply.
K Bykov, JJ Gagne - JAMA, 2022 - europepmc.org
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply. - Abstract …
Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply. - Abstract …